95 related articles for article (PubMed ID: 28087665)
1. NKG2D Promotes B1a Cell Development and Protection against Bacterial Infection.
Lenartić M; Jelenčić V; Zafirova B; Ožanič M; Marečić V; Jurković S; Sexl V; Šantić M; Wensveen FM; Polić B
J Immunol; 2017 Feb; 198(4):1531-1542. PubMed ID: 28087665
[TBL] [Abstract][Full Text] [Related]
2. NKG2D: A versatile player in the immune system.
Jelenčić V; Lenartić M; Wensveen FM; Polić B
Immunol Lett; 2017 Sep; 189():48-53. PubMed ID: 28414183
[TBL] [Abstract][Full Text] [Related]
3. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
4. The activating receptor NKG2D of natural killer cells promotes resistance against enterovirus-mediated inflammatory cardiomyopathy.
Klingel K; Fabritius C; Sauter M; Göldner K; Stauch D; Kandolf R; Ettischer N; Gahlen S; Schönberger T; Ebner S; Makrigiannis AP; Bélanger S; Diefenbach A; Polić B; Pratschke J; Kotsch K
J Pathol; 2014 Oct; 234(2):164-77. PubMed ID: 24797160
[TBL] [Abstract][Full Text] [Related]
5. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
6. NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
Legroux L; Moratalla AC; Laurent C; Deblois G; Verstraeten SL; Arbour N
Front Immunol; 2019; 10():154. PubMed ID: 30787931
[TBL] [Abstract][Full Text] [Related]
7. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
[TBL] [Abstract][Full Text] [Related]
8. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease.
Wortham BW; Eppert BL; Motz GT; Flury JL; Orozco-Levi M; Hoebe K; Panos RJ; Maxfield M; Glasser SW; Senft AP; Raulet DH; Borchers MT
J Immunol; 2012 May; 188(9):4468-75. PubMed ID: 22467655
[TBL] [Abstract][Full Text] [Related]
9. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R
Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313
[TBL] [Abstract][Full Text] [Related]
10. The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.
Stojanovic A; Correia MP; Cerwenka A
Front Immunol; 2018; 9():827. PubMed ID: 29740438
[TBL] [Abstract][Full Text] [Related]
11. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R
Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123
[TBL] [Abstract][Full Text] [Related]
12. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
[TBL] [Abstract][Full Text] [Related]
13. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.
Zafirova B; Mandarić S; Antulov R; Krmpotić A; Jonsson H; Yokoyama WM; Jonjić S; Polić B
Immunity; 2009 Aug; 31(2):270-82. PubMed ID: 19631564
[TBL] [Abstract][Full Text] [Related]
14. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes.
Van Belle TL; Ling E; Haase C; Bresson D; Ursø B; von Herrath MG
J Autoimmun; 2013 Feb; 40():66-73. PubMed ID: 22944096
[TBL] [Abstract][Full Text] [Related]
15. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
[TBL] [Abstract][Full Text] [Related]
16. Effects of NKG2D haplotypes on the cell-surface expression of NKG2D protein on natural killer and CD8 T cells of peripheral blood among atomic-bomb survivors.
Imai K; Hayashi T; Yamaoka M; Kajimura J; Yoshida K; Kusunoki Y; Nakachi K
Hum Immunol; 2012 Jun; 73(6):686-91. PubMed ID: 22507622
[TBL] [Abstract][Full Text] [Related]
17. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
19. [Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].
Tu SF; Guo KY; Hu LS; Mei JZ; Zhou J; Sun M
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):341-3, 347. PubMed ID: 18394338
[TBL] [Abstract][Full Text] [Related]
20. Cattle MIC is a ligand for the activating NK cell receptor NKG2D.
Guzman E; Birch JR; Ellis SA
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):227-34. PubMed ID: 20399506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]